Filters
total: 21314
filtered: 805
-
Catalog
Chosen catalog filters
Search results for: UNRESCOARSE GRAINING
-
Molecularly targeted nanoparticles: an emerging tool for evaluation of expression of the receptor for advanced glycation end products in a murine model of peripheral artery disease
PublicationAbstract Background: Molecular imaging with molecularly targeted probes is a powerful tool for studying the spatio-temporal interactions between complex biological processes. The pivotal role of the receptor for advanced glycation end products (RAGE) in numerous pathological processes, aroused the demand for RAGE targeted imaging in various diseases. In the study, we evaluated the use of a diagnostic imaging agent for RAGE quantification...
-
CSR at HEIs: Between Ignorance, Awareness and Knowledge
PublicationThe paper focuses on CSR education in Higher Education Institutions. It analyzes current approaches to this education and the enhancements already deployed in the international perspective. The main aim is to conceptualize CSRS education forms within the context of technology-oriented HEIs and propose the model for this education. This model has also been partially verified using the cases of four technical universities. This research...
-
Evaluating the challenges and needs of parents caring for children with Williams syndrome: A preliminary study from Poland
PublicationBackground: Although physical, cognitive and behavioural manifestations of Williams syndrome(WS) affect every dimension of caregivers lives, no studies on the parental experiences of caringfor a WS child have to date been carried out in Poland.Methods: In order to identify the challenges and needs of Polish carers of WS children a survey wasconducted...
-
Antitumor 1-nitroacridine derivative C-1748 induces significant apoptosis in pancreatic cancer cells.
PublicationPancreatic cancer is the fifth leading cause of cancer death and has the lowest survival rate of any solid cancer in the industrial countries. The poor prognosis of pancreatic cancer results from its tendency for late presentation, aggressive invasion, early metastasis, and resistance to chemotherapy. Gemcitabine still remains the best chemotherapeutic agent available for the treatment of advanced pancreatic cancer. However, gemcitabine...
-
40th EASD Annual Meeting of the European Association for the Study of Diabetes
Publication